Cart
sales@molnova.com
threo-Guaiacylglycerol beta-coniferyl ether
CAS No. 869799-76-8
threo-Guaiacylglycerol beta-coniferyl ether( —— )
Catalog No. M31083 CAS No. 869799-76-8
Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 531 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namethreo-Guaiacylglycerol beta-coniferyl ether
-
NoteResearch use only, not for human use.
-
Brief DescriptionThreo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
-
DescriptionThreo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869799-76-8
-
Formula Weight376.4
-
Molecular FormulaC20H24O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[D-Ser13]-Somatostat...
[D-Ser13]-Somatostatin-14
-
GPX4-IN-5
GPX4-IN-5 is a small molecule covalent GPX4 inhibitor (IC50: 0.12 μM) with antitumour activity.
-
SARS-CoV-2 Mpro-IN-9
SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.
